Sign In

Sabine Bahn

Professor of Neurotechnology at University of Cambridge

Sabine Bahn is a prominent academic and researcher in the field of neurotechnology and psychiatry. She serves as a Professor of Neurotechnology and Director of the Cambridge Centre for Neuropsychiatric Research at the University of Cambridge. Additionally, she holds a position as a Professor of Translational Neuropsychiatry at the Erasmus Medical Centre in Rotterdam, Netherlands.

Academic Background and Research Focus

Bahn's academic journey includes obtaining her MD from the University of Freiburg, Germany, and completing her PhD at the MRC Laboratory of Molecular Biology in Cambridge. Her research primarily investigates the molecular basis of neuropsychiatric disorders, particularly focusing on schizophrenia and mood disorders. The Bahn Laboratory employs various molecular profiling techniques to explore abnormalities in tissues, blood, and other biological samples from patients with psychiatric conditions.123

Contributions and Achievements

Professor Bahn has made significant contributions to the field, having published over 180 articles in high-impact scientific journals. She is recognized for her role in founding two notable companies: Psynova Neurotech, which developed the first blood test for early diagnosis of schizophrenia, and Psyomics, aimed at improving mental health diagnostics through digital tools and biomarkers.123 Her work has garnered numerous awards, including being elected as a Fellow of the Royal Society of Biology in 2015.

Professional Roles

In addition to her academic roles, Bahn is a practising psychiatrist and an honorary consultant at the Peterborough and Cambridge NHS Trust. She has been involved in various initiatives to enhance the understanding and treatment of mental health disorders through innovative research approaches.123

Summary

Sabine Bahn's extensive expertise in neurotechnology and psychiatry positions her as a leading figure in advancing research and treatment methodologies for neuropsychiatric disorders. Her dual focus on empirical research and clinical practice underscores her commitment to bridging the gap between scientific discovery and patient care.

Related Questions

What are some of Sabine Bahn's most notable achievements in the field of neuropsychiatry?
How does the Bahn Laboratory contribute to the understanding of neuropsychiatric diseases?
What are the main goals of Psyomics Ltd. and how does it differ from Psynova Neurotech?
Can you provide more details about the blood test for schizophrenia developed by Psynova Neurotech?
What is the significance of Sabine Bahn being a Fellow of the Royal Society of Biology?
S
Add to my network

Location

Cambridge, England, United Kingdom